Results 281 to 290 of about 33,638 (296)
Some of the next articles are maybe not open access.

Acute Panmyelosis with Myelofibrosis

Leukemia & Lymphoma, 2004
Acute panmyelosis with myelofibrosis (APMF) is an ill-defined disorder that may either evolve as a clonal hematopoietic condition or as a sequel of toxic exposure to the bone marrow (BM). Therefore, controversy and discussion continues as to whether APMF may be considered as a hyperfibrotic (de novo) myelodysplastic syndrome (MDS), as acute myeloid ...
Thiele, Juergen   +2 more
openaire   +4 more sources

Myelofibrosis with myeloid metaplasia

Hematology/Oncology Clinics of North America, 2003
MMM is a chronic myeloproliferative disorder characterized by bone marrow fibrosis and neoangiogenesis, constitutive release ofa high number of CD34+ stem cells from the bone marrow, and extramedullary hematopoiesis. It presents with heterogeneous clinical features in which anemia and progression to symptomatic splenomegaly dominate.
openaire   +3 more sources

An unusual myelofibrosis

Blood, 2022
Véronique Vergé, Peggy Dartigues
openaire   +2 more sources

Myelofibrosis

Radiology, 1961
W T, MESZAROS, M, SISSON
openaire   +2 more sources

Myelofibrosis

2018
The main objectives of this chapter are to review the wide array of toxicologic insults that may result in bone marrow damage and subsequent development of bone marrow fibrosis (myelofibrosis) in humans and animals. Etiologic and morphologic features of primary myelofibrosis (a clonally derived myeloproliferative neoplastic disease) are compared to ...
openaire   +2 more sources

On Myelofibrosis

Archives of Internal Medicine, 1956
D R, KORST   +2 more
openaire   +2 more sources

Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia

Springer Seminars in Immunopathology, 2000
Marie-Claire Martyré   +1 more
openaire   +2 more sources

Splenectomy in Myelofibrosis

Acta Medica Scandinavica, 1964
openaire   +2 more sources

Home - About - Disclaimer - Privacy